Search Results

HRP19 Management of Change Manager's Guide - Appendix 8 Outcome of Consultation - Changes Letter.docx

Disclosure Ref 2024245 - Collabrative working with pharmaceutical companies.pdf

Freedom of information disclosure relating to collaborative working with pharmaceutical companies

Tier 3 Specialist Weight Management Service Operational SOP (S157)

The guidance defines what the patient journey through the Tier 3 Specialist Weight Management Service should look like, including: • How referrals are received • How referrals out of the service are completed (to Tier 2 and Tier 4 services) • Clinical thresholds and triage criteria • Patient flow and program content • Prescribing initiation and transition points • MDT roles and responsibilities • Discharge process It also aims to ensure equitable access, clinical safety and consistency in triage and discharge decisions across localities.

Corporate Framework August 2025

Corporate Framework August 2025

0535 - Anticoagulation Maintenance Referral Form

0535 - Anticoagulation Maintenance Referral Form

0003 - Continuing Health Care Consent and Basic Information Form

0003 - Continuing Health Care Consent and Basic Information Form

0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19 (P69)

0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19

1187 - Enhanced Observation Competency Check List

1187 - Enhanced Observation Competency Check List

L268 - Use of steroid ointments and creams in the treatment of varicose eczema - Information for patients with venous leg ulcers

L268 - Use of steroid ointments and creams in the treatment of varicose eczema - Patient Information Leaflet for patients with venous leg ulcers.

Local Decontamination Of Reusable Medical Devices-Dental and Podiatry Services (P16)

The aim of this policy is to detail the practices and principles for the local decontamination of reusable medical devices, with reference to podiatric services.